NCT05057117View on ClinicalTrials.gov

Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

October 17, 2022

Study Completion Date

April 24, 2023

Conditions
Hyperhidrosis Primary Focal Axilla
Interventions
DEVICE

Microwave thermolysis

Baseline treatment with microwave thermolysis in one axilla and botulinum toxin A in the contralateral axilla, as allocated by randomization

DRUG

Botulinum toxin A

Baseline treatment with microwave thermolysis in one axilla and botulinum toxin A in the contralateral axilla, as allocated by randomization

Trial Locations (1)

2400

Department of Dermatology, Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Merete Haedersdal

OTHER

NCT05057117 - Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis | Biotech Hunter | Biotech Hunter